Replies to post #161624 on NorthWest Biotherapeutics Inc (NWBO)

[manibiotech]

I agree , the blinded data won’t have significant effect on SP in opinion either . Problem is the timing . When market is expecting unblinded Top line data in May and you present them with a year old blinded data , don’t think market will be very impressed . I believe it will be too little too late . But let’s wait and see . Market has mysterious ways